Inge Vrelust

543 total citations
13 papers, 94 citations indexed

About

Inge Vrelust is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Inge Vrelust has authored 13 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Inge Vrelust's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (3 papers) and Immunotherapy and Immune Responses (3 papers). Inge Vrelust is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (3 papers) and Immunotherapy and Immune Responses (3 papers). Inge Vrelust collaborates with scholars based in Belgium, Netherlands and Austria. Inge Vrelust's co-authors include Alain Gadisseur, Chris H. Bridts, Peter Valent, Vito Sabato, Geert Mortier, Els Van de Vijver, Edwin Reyniers, Erik Fransén, Didier G. Ebo and Margo M. Hagendorens and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Inge Vrelust

13 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Vrelust Belgium 6 41 25 19 18 17 13 94
Rebeca Goiriz Spain 8 57 1.4× 15 0.6× 13 0.7× 7 0.4× 16 0.9× 17 131
Pierre Hirsch France 4 41 1.0× 24 1.0× 8 0.4× 33 1.8× 7 0.4× 16 114
Rebeca Rodríguez Pena Spain 4 50 1.2× 9 0.4× 6 0.3× 14 0.8× 10 0.6× 12 80
Erik Gaitzsch Germany 7 42 1.0× 22 0.9× 5 0.3× 44 2.4× 11 0.6× 8 109
Katrien Pieters Sweden 5 68 1.7× 15 0.6× 14 0.7× 44 2.4× 5 0.3× 8 111
Erika Van Nieuwenhove Belgium 8 59 1.4× 21 0.8× 5 0.3× 53 2.9× 11 0.6× 13 132
Sandra Mueller‐Schmucker Germany 5 60 1.5× 9 0.4× 6 0.3× 75 4.2× 10 0.6× 8 173
Felix A. Radtke Germany 5 43 1.0× 23 0.9× 8 0.4× 27 1.5× 7 0.4× 6 91
Rebecca Schleicher Germany 2 43 1.0× 24 1.0× 6 0.3× 45 2.5× 7 0.4× 2 91
Alba Garrido-Trigo Spain 3 26 0.6× 8 0.3× 5 0.3× 13 0.7× 10 0.6× 5 75

Countries citing papers authored by Inge Vrelust

Since Specialization
Citations

This map shows the geographic impact of Inge Vrelust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Vrelust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Vrelust more than expected).

Fields of papers citing papers by Inge Vrelust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Vrelust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Vrelust. The network helps show where Inge Vrelust may publish in the future.

Co-authorship network of co-authors of Inge Vrelust

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Vrelust. A scholar is included among the top collaborators of Inge Vrelust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Vrelust. Inge Vrelust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Devos, Timothy, Koen Theunissen, Fleur Samantha Benghiat, et al.. (2018). Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients in Real-World Clinical Practice: Data from a Belgian Registry. Blood. 132(Supplement 1). 1744–1744. 3 indexed citations
3.
Maes, Brigitte, Bert Cruys, M. Janssen, et al.. (2017). Targeted next‐generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics. International Journal of Laboratory Hematology. 39(6). 604–612. 7 indexed citations
4.
Sabato, Vito, Els Van de Vijver, Margo M. Hagendorens, et al.. (2014). Familial hypertryptasemia with associated mast cell activation syndrome. Journal of Allergy and Clinical Immunology. 134(6). 1448–1450.e3. 38 indexed citations
5.
6.
Berneman, Zwi, Ann Van de Velde, Sébastien Anguille, et al.. (2013). Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients. Blood. 122(21). 236–236. 7 indexed citations
7.
Berneman, Zwi, Ann Van de Velde, Sébastien Anguille, et al.. (2012). WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.. Journal of Clinical Oncology. 30(15_suppl). 2506–2506. 4 indexed citations
8.
Vrelust, Inge, et al.. (2012). Phialemonium curvatum fungaemia in an immunocompromised patient: case report.. PubMed. 66(5). 384–6. 6 indexed citations
9.
Patteet, Lisbeth, Katrien Vermeulen, Katrien Pieters, et al.. (2012). A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature.. PubMed. 67(1). 34–8. 4 indexed citations
10.
Perkisas, Stany, et al.. (2011). A warning about agranulocytosis with the use of cocaine adulterated with levamisole.. PubMed. 66(3). 226–7. 5 indexed citations
11.
Bracke, An, Erika Vlieghe, Alain Gadisseur, et al.. (2010). MEDICAL AND SURGICAL MANAGEMENT OF PARANEOPLASTIC PYODERMA GANGRENOSUM - A CASE REPORT AND REVIEW OF THE LITERATURE. Acta Clinica Belgica. 65(1). 37–40. 9 indexed citations
12.
Berneman, Zwi, Ann Van de Velde, Ann Van Driessche, et al.. (2008). Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia. Blood. 112(11). 830–830. 2 indexed citations
13.
Vrelust, Inge, et al.. (2007). Identification of a novel candidate splice site mutation (0874+1G>A) in a type 3 von Willebrand disease patient. Thrombosis and Haemostasis. 98(8). 464–466. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebeca Goiriz Breakdown of academic impact, for papers by Pierre Hirsch Breakdown of academic impact, for papers by Rebeca Rodríguez Pena Breakdown of academic impact, for papers by Erik Gaitzsch Breakdown of academic impact, for papers by Katrien Pieters Breakdown of academic impact, for papers by Erika Van Nieuwenhove Breakdown of academic impact, for papers by Sandra Mueller‐Schmucker Breakdown of academic impact, for papers by Felix A. Radtke Breakdown of academic impact, for papers by Rebecca Schleicher Breakdown of academic impact, for papers by Alba Garrido-Trigo
Rankless by CCL
2026